Psyence Group Income Statement

Financials in millions CAD. Fiscal year is April - March.

Millions CAD. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Selling, General & Admin	5.03	3.58	3.58	4.34	3.77
Research & Development	0.48	1.58	2.3	0.12	0.03
Operating Expenses	5.52	5.26	5.97	4.51	3.82
Operating Income	-5.52	-5.26	-5.97	-4.51	-3.82
Interest Expense	-0.01	-0.07	-0.12	-0	-0
Interest & Investment Income	0.13	0	0.01	-	-
Earnings From Equity Investments	-	-	-0.13	-0.09	-
Currency Exchange Gain (Loss)	0	0.01	-0.01	-0.01	-0.03
Other Non Operating Income (Expenses)	0.71	-57.69	0.19	-	-9.68
EBT Excluding Unusual Items	-4.68	-63.01	-6.04	-4.6	-13.54
Gain (Loss) on Sale of Assets	-0.54	-	-	-	-
Other Unusual Items	5.2	-6.44	-0.05	-	-
Pretax Income	-0.03	-69.45	-6.08	-4.6	-13.54
Earnings From Continuing Operations	-0.03	-69.45	-6.08	-4.6	-13.54
Minority Interest in Earnings	-0.37	41.59	-	-	-
Net Income	-0.4	-27.85	-6.08	-4.6	-13.54
Net Income to Common	-0.4	-27.85	-6.08	-4.6	-13.54
Shares Outstanding (Basic)	9	9	6	6	-
Shares Outstanding (Diluted)	9	9	6	6	-
Shares Change (YoY)	5.04%	49.80%	4.07%	-	-
EPS (Basic)	-0.04	-3.13	-1.03	-0.81	-
EPS (Diluted)	-0.04	-3.13	-1.03	-0.81	-
Free Cash Flow	-5.56	-5.9	-3.91	-3.72	-3.07
Free Cash Flow Per Share	-0.60	-0.66	-0.66	-0.65	-
EBITDA	-5.51	-5.17	-5.88	-4.46	-3.8
D&A For EBITDA	0.01	0.09	0.09	0.05	0.03
EBIT	-5.52	-5.26	-5.97	-4.51	-3.82

Source: S&P Global Market Intelligence. Standard template. Financial Sources.